Trends in HIV Preexposure Prophylaxis Prescribing in the United States, 2012-2018

This study uses national pharmacy claims data to describes trends in prescriptions for HIV preexposure prophylaxis (PrEP) overall and by specialty between 2012 and 2018.

Saved in:
Bibliographic Details
Published inJAMA : the journal of the American Medical Association Vol. 324; no. 4; pp. 395 - 397
Main Authors Song, Hyun Jin, Squires, Patrick, Wilson, Debbie, Lo-Ciganic, Wei-Hsuan, Cook, Robert L, Park, Haesuk
Format Journal Article
LanguageEnglish
Published United States American Medical Association 28.07.2020
Subjects
Adolescent
Adult
Anti-HIV Agents - therapeutic use
Drug Utilization - trends
Female
HIV
HIV Infections - prevention & control
Human immunodeficiency virus
Humans
Letter
Letters
Male
Middle Aged
Practice Patterns, Physicians' - trends
Pre-Exposure Prophylaxis - trends
Prophylaxis
Research Letter
United States
Young Adult
United States
Online AccessGet full text

Cover

More Information
Summary:This study uses national pharmacy claims data to describes trends in prescriptions for HIV preexposure prophylaxis (PrEP) overall and by specialty between 2012 and 2018.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2020.7312